Delivery Order SPE2DB24D1205-SPE2DB25FCQUS
Award Date
10/15/24
Potential Completion Date
10/16/24
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,676.83, is for the supply of ONTRUZANT 420 MG VIALS, a medical product. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ONTRUZANT 420 MG VIALS, a medical product, with a ceiling value of $17,781.12 and a performance period through October 30, 2024. The contract is a firm-fixed price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,676.48, is for the supply of 4566842976 ONTRUZANT 420 MG VIALS. It is a firm fixed-price delivery order contract, with a period of performance through January 7, 2025. The contract was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $62,776.72 contract is for the delivery of 4,565,631,436 vials of the pharmaceutical product ONTRUZANT 420 MG. The order has an ultimate completion date of August 30, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the federal government, was awarded this delivery order through the company's Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product, with a completion date of February 12, 2024 and a potential value of $14,364.60. The contract does not have a set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of ONTRUZANT 150 MG VIALS. The contract has a ceiling value of $4,354.03 and is a firm fixed price delivery order. The contract has a period of performance through July 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $27,236.77, is for the delivery of ONTRUZANT 420 MG VIALS medical products. The contract has an ultimate completion date of February 21, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of ONTRUZANT 420 MG VIALS. The contract has a total ceiling value of $72,254.30 and an ultimate completion date of November 28, 2023. This is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order awarded to AmerisourceBergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,305.10 firm-fixed-price contract is for the supply of ONTRUZANT 150 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, particularly the Department of Defense and other federal...
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,212.42, is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product. The contract has a completion date of February 27, 2025 and is structured as a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC)...